Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shingrix
Pharma
Shingrix surge, Exdensur flop highlight GSK CEO’s first quarter
A boost from the U.S. market and strong demand in Europe lifted Shingrix’s global Q1 sales to a new quarterly record of £1.03 billion.
Angus Liu
Apr 29, 2026 10:47am
As CEO, Luke Miels wants GSK to be more 'product-centric'
Feb 4, 2026 9:40am
Emma Walmsley upholds £40B sales target in final GSK CEO report
Oct 29, 2025 11:14am
GSK's Emma Walmsley to step down as CEO in shock move
Sep 29, 2025 3:39am
GSK raises long-term sales goal—again—despite vaccines woes
Feb 5, 2025 11:06am
Sanofi, GSK and China reimbursement updates—Fierce Pharma Asia
Dec 6, 2024 9:00am
